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SYNERGISTIC METHOD FOR HOST CELL 
TRANSFORMATION 
FIELD OF INVENTION 
This invention relates to the ?eld of molecular biol 
ogy and, in particular, the ?eld of genetic engineering. 
More particularly, this invention relates to protocols for 
transfection of cells. Most particularly, the invention 10 
describes a new and highly ef?cient, transformation 
protocol. 
BACKGROUND OF THE INVENTION 
Much excitement has been generated in the technical, 
scienti?c and lay communities about the potential bene 
?ts arising from the developments of genetic engineer 
ing technology. Most frequently, public attention and 
praise are focused on the pharmacological and public 
health bene?ts associated with genetic engineering. 
Examples of the genetically engineered pharmaceutical 
products that have been given kudos include genetically 
. engineered tissue, plasminogen activator and, more re 
cently, erythropoietin. 
It is understandable that these pharmaceutical and 
public health related achievements have garnered much 
of the public attention surrounding genetic engineering. 
However, application of genetic engineering technol 
ogy to nonpharmaceutical related areas holds the same 
excitement and promise as application of genetic engi 
neering technology to the public health sector. In par 
ticular, the application of genetic engineering tools to 
agricultural products, both plant and animal, holds out 
the exciting prospect of disease and pest resistant ani 
mals and plants. In this connection, great energies have 
been spent in these ?elds as well as public health ?elds 
to perfect or optimize the genetic engineering methods 
used by scientists to create these bene?cial fruits of 
genetically engineered products. 
This invention is not the type of genetically engi 
neered discovery that appears on the front pages of 
newspapers, on the radio or on television. The “sex 
appeal” that is required to achieve such notoriety is not 
a part of this invention. Rather, this invention is princi 
pally directed to the methodology of genetic engineer 
ing. It is envisioned that the application of the method 
ology taught by this invention will someday result in 
the creation of a genetically engineered plant, animal or 
drug that will achieve the type of notoriety which re 
sults in extensive media coverage. 
Many lay individuals who otherwise understand and, 
indeed, marvel at the bene?ts genetic engineering holds 
for society, do not fully appreciate the high degree of 
technical skill required to establish a scienti?c method 
ology or protocol that permits the actual genetic manip 
ulation of cells. At the most basic level, genetic engi 
neering is the transfer or movement of the “chemical 
blueprint” of cells, as encoded in nucleic acids, from 
one cell in which such a chemical blueprint naturally 
occurs to another cell, called the host cell, that does not 
naturally contain the chemical blueprint. It is important 
that this transfer occur in such a way that the host cell 
can accurately read and express the chemical blueprint 
even though the blueprint is not its own. 
One of the many technical dif?culties of genetic engi 
neering is to ?nd a way to move the chemical blueprint, 
called deoxyribonucleic acid (DNA), from the cell in 
which it naturally occurs into the host cell. This prob 
lem of DNA movement required to transfect or trans 
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form a host cell is particularly acute in the case of plant 
host cell transformation, although the problem is cer 
tainly also prevalent in the transformation of other cel 
lular life forms. 
Various methodologies have been introduced into the 
genetic engineering ?eld to facilitate this transfer of 
DNA from one cell to another. Included in such trans 
fer technologies are the methods of electroporation, 
high velocity microprojectiles, polyethylene glycol 
(PEG) transformation, calcium phosphate, microinjec 
tion and Aqrobacterium-mediated transformation. 
Problems, particularly with DNA transformation of 
cells especially plant cells and most especially monocot 
plant cells such as corn (maize), are extant with allthese 
methodologies. 
For example, electroporation is many times an inef? 
cient and highly costly methodology. Although elec 
troporation is a reliable procedure, it results in pro 
nounced loss of cell viability (3, 7) caused by, among 
other factors, destruction of the cell membrane and/or 
of cell wall integrity. Microprojectiles are cumbersome 
to use, costly and, as their name implies, damaging to 
cell membranes and/or cell walls causing signi?cant 
loss of cell viability by virtue of the fact that a bullet 
like projectile is being "shot” into the host cell. Aoro 
bacterium-mediated DNA transformation is a painstak 
ing process. In addition, it is not useful for monocot 
plant species generally because certain species are not 
susceptible to infection or transformation by Aqrobac 
terium bacteria, a step necessary for subsequent DNA 
transfer. The PEG methodology for host cell transfec 
tion is an extremely dif?cult methodology over which a 
genetic engineering researcher has somewhat minimal 
control and this methodology is highly toxic to cells 
generally. In addition to the dif?culties associated with 
the aforementioned methodologies, all DNA transfor 
mation techniques must address the problem of intro 
ducing foreign DNA into a host cell so that the foreign 
DNA manifests some signi?cant stability in the host cell 
thereby achieving the ultimate aim of genetic transfor 
mation-to stably express the transformed DNA chemi 
cal in a host cell. This is referred to as stable transforma 
tion of the host. 
Achieving stable host transformation is a problem 
that extends across all forms of cellular life. However, 
the problem is especially acute in plant cells. Unlike 
animal cells that have no cell walls, plant cells have 
cellulosic cell walls. It is a characteristic of these cell 
walls that they are very dif?cult to penetrate. Accord 
ingly, transformation of plant cells has proved more 
dif?cult than transformation of other cells because sci 
entists attempting to transform nonplant cells‘ need not 
deal with the complex problems of moving DNA across 
the cellulosic plant cell wall. Thus, it is easier to move 
DNA into an animal cell than a plant cell. Scientists 
have surmounted this problem by modifying plant cells 
so that the cellulosic cell wall is removed providing 
direct access to the plant cell membrane. (Because ani 
mal cells lack cell walls, membranes form the outer 
boundary of animal cells.) Plant cells lacking cell walls 
are termed protoplasts or naked cells. Because the cell 
wall is removed from these plant cells, the ability to _ 
transform such cells with nonnative DNA is increased. 
In most cases, the cell walls regenerate in 6-24 hours. 
The achievement of stable transformation is a relative 
criterion that is principally a function of the time in 
which foreign DNA is inside a host cell and in which 
5,286,634 
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the host cell maintains the ability to express the trans 
formed DNA. In plants and in animals such stable trans 
formation is best achieved by methods which lead to the 
incorporation of the foreign DNA into chromosomes. 
However, stable integration especially in animal cells 
can be achieved with certain vectors that replicate 
freely in animal cells without integration into chromo 
somes. Until stable transformation is achieved, the 
transformation is said to be transient. Obviously, any 
host cell that has been stably transformed has passed 
through a stage at which it could only be said that the 
host cell was transiently transformed. However, it must 
be appreciated that transient transformation of a cell 
(and transient expression of the transformed DNA) is 
not a guarantor that stable transformation will occur. 
Among the reasons for this is the relative unpredictabil 
ity of biological systems. 
The transformation technique of this invention is a 
simple and elegant protocol that uses two common, 
relatively inexpensive “off-the-shelt" chemicals in a 
combined or coordinated manner such that a synergistic 
effect between the two chemicals results as manifest by 
extremely efficient DNA transformation in all cells, 
most notably in plant cells and especially notably in 
monocot plant cells. Indeed, the two chemicals that are 
combined by this invention, a polycation compound and 
a cationic liposome compound, have been used individ 
ually to effect DNA transformation. Although other 
researchers have combined DNA transformation meth 
odologies in the past, in particular combining the tech 
niques of PEG and electroporation (29), the reports of 
the alleged success of this latter combination have been 
dubiously received by the scienti?c community. Re 
gardless of that, the combination of the present inven 
tion results in a very efficient transformation, signi? 
cantly greater than the PEG and electroporation com 
bination even assuming that such a combination is effec 
tive. Thus, this ‘invention teaches a methodology 
termed 2PC that permits transient and stable transfor 
mation of host cells. 
This invention employs two common chemicals used 
in an extremely simple methodology that does not re 
quire sophisticated machinery or great expense. Ac 
cordingly, this invention has great application for all 
genetic engineering laboratory undertakings, whether 
in highly sophisticated molecular biology research labs 
such as are extant in major universities and corporations 
throughout the world, or whether in simple laboratory 
settings such as in a high school biology laboratory. 
It is therefore an object of the present invention to 
provide a method for transforming a host cell. More 
particularly, it is an object of this invention to provide a 
method for transformation of plant cells, especially 
monocot plant cells. 
It is a further object of this invention to provide a 
method of cell transformation that is applicable to all 
cells and that employs relatively low technology means 
thus providing for the 'use of this technology by a broad 
spectrum of laboratories. 
It is a still further object of this invention to provide 
for transformed cells that have been transformed by the 
synergistic action of a polycation compound and a cati 
onic liposome to effect both transient and stable trans 
formation of the host cell. 
SUMMARY OF THE INVENTION 
This invention addresses the problem of inserting 
foreign or nonnative DNA into a cell and, most particu 
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larly, into a plant cell. The solution to this problem of 
DNA transfer set forth in this invention is the use of a 
polycationic compound and cationic liposomes which 
act synergistically to accomplish host cell transforma 
tion. 
According to this invention, a recombinant cell can 
be made comprising nonnative and native DNA in 
which the nonnative DNA is introduced into the cell by 
the coordinated use of a polycation compound and a 
cationic liposome compound during transfection of the 
cell thereby transforming the cell. Any type of cellular 
life form can be so transformed although the invention 
is most efficient when used with a cell lacking a cell 
wall, that is, a cell having an outer boundary that is a 
membrane. Types of cells having a membrane as an 
outer boundary include mammalian cells and proto 
plasts of either monocotyledonous or dicotyledonous 
plant cells. 
Transformation of cells according to this invention is 
accomplished by treating a host cell for a predeter 
mined time with a solution of a polycation compound 
thus forming a cell polycation complex. DNA nonna 
tive to the host cell is treated with a suspension of cati 
onic liposomes to form a DNA liposome complex. 
Thereafter the cell polycation complex and the DNA 
liposome complex are combined giving rise to a syner 
gistic effect that transforms the host cell with nonnative 
DNA. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1. CAT activity after transfection of BMS-M 
with cationic methods. Enzyme activity is expressed as 
% conversion of 14C chloramphenicol to monoacety 
lated forms per 100 mg rotein ' polycation com 
pound-treated protoplasts, cationic liposome-treated 
protoplasts, 2PC- protoplast. 
FIG. 2. Autoradiogram of a thin layer chromatogra 
phy (TLC) plate showing acetylated products of 14C 
chloramphenicol after transfection of BMS-M with 
varying DNA concentrations by polycation compound, 
cationic liposome or 2PC methods. A, unreacted l4C 
chloramphenicol; B, l-acetylchloramphenicol; C, 3 
acetyl chloramphenicol. PLCF, also termed 2PC. 
FIG. 3. Autoradiogram of TLC plate showing CAT 
gene expression after 2PC transfection of Al88/Mu2 
protoplasts with 20 ug pCaMVI,CN. Lanes: 1, E. coli 
standard; 2, BMS-M untreated protoplasts plus DNA; 3, 
BMS-M protoplasts treated with cationic liposome and 
DNA; 4, BMS-M protoplasts transfected by 2PC and 
DNA. 
FIG. 4. Viability of BMS-M protoplasts after trans 
fection by cationic methods. 
m Control. 
[UIHIU polycation compound-treated. 
m cationic liposome-treated. 
m 2PC treated. 
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FIG. 5. Method for selection of stable Kan ® trans 
formants after pCaMVNeo transfection. Inset shows 
fast-growing BMS-M transformants'after 7 d on me 
dium with 200 ug/ml kanamycin. 
FIG. 6. Integration of nptII in genomic DNA of two 
independently selected 'Kan ® transformants obtained 
by 2PC transfection. Genomic DNAs were digested 
with EcoRV and probed with the BamI-II nptII frag 
ment of pCaMVNeo. EcoRV enzyme cuts at one 
EcoRV site within the CaMV promoter of the donor 
DNA (or cassette), and also cuts at EcoRV sites at 
different positions in maize DNA adjacent to the site of 
insertion of the donor DNA, thus revealing the integra 
tion of donor DNA in the transfected host cell. Lanes: 
a, DNA from nontransformed BMS-M; b, DNA from 
'BMS-M stably transformed with pCaMVNeo by the 
PEG method; c,d, DNA from two stable BMS-M 
Kan @ transformants after transfection with 
pCaMVNeo by the 2PC method. 
FIG. 7. Phosphorylation of kanamycin by nptII genes 
integrated into BMS-M following 2PC transfection. 
The reaction products were separated on TLC plates 
and detected by autoradiography. Lanes: 1 and 5, 
BMS-M control; 2,3 and 4, BMS-M transformed with 
nptII., phosporylated Kanamycin. 
FIG. 8. Integration of the GUS gene in BMS-M 
(maize) and NTI (tobacco) stable transformants after 
transfection of pZASO by 2PC methods. Genomic 
DNAs probed with a Pstl, EcoRI fragment from 
pZA50 containing CaMV35S, the GUS structure gene, 
and nos 3'. Lanes: pBI22l, the parent plasmid used in 
pZA50 construction and containing the same Pstl 
EcoRI fragment; BMS, stable 2PC-mediated maize 
transformant; NTI, stable 2PC-mediated GUS transfor 
mant in tobacco. 
FIG. 9. Electrophoresis of plasmid DNA previously 
mixed with varying quantities of cationic liposome. For 
each sample in lanes 2-4, 2 ug of pZASO was reacted 
with the following concentrations of cationic liposome 
to give the indicated DNA:cationic liposome ratios in 
parentheses. Lanes: 2, 2 ul cationic liposome (1:1); 3,5 ul 
cationic liposome (1:2.5); 4, 10 ul cationic liposome 
(1:5). Samples in lanes 5, 6, and 7 had 2 ug pZASO plus 
2, 5, and 10 ul cationic liposome respectively, plus 30 ug 
polycation compound each. Lane 1 contains only 2 ug 
plasmid DNA. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The recombinant cells and recombinant methodolo 
gies disclosed herein provide for highly efficient trans 
formation of cells. This invention represents an advance 
over the known methods of transformation by virtue of 
the demonstrated effectiveness of the methodologies 
and by the established application of the methodologies 
to regenerable cell lines. 
Many of the procedures associated with practicing 
the non-inventive steps of the protocol needed to prac 
tice this invention have been elucidated and are set forth 
in publications available in scienti?c libraries and the 
like. The more pertinent publications are listed in the 
Bibliography annexed hereto. In these instances, the 
publications are identi?ed using a numerical code sys 
tem in which each reference listed in the Bibliography is 
identi?ed by a unique arabic numeral. All the references 
listed in the Bibliography or otherwise identi?ed herein 
are hereby incorporated by reference. 
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Using the techniques of this invention, transient and 
stable activity of nonnative genes in host cells has been 
demonstrated. In particular, such activity has been 
shown in plant cells derived from both monocotyledon 
ous and dicotyledonous plants. Transformation of cells 
from other kingdoms including animal cells using this 
methodology are also achievable. 
This invention exploits the known properties of two 
relatively simple and inexpensive chemicals. In particu 
lar, the invention sets forth that these two chemicals, a 
polycation compound and cationic liposomes, can be 
used in a coordinated fashion to signi?cantly increase 
the likelihood of obtaining transformed cells. As noted, 
use of polycation compounds and cationic liposomes 
individually for cellular transformation is known but 
heretofore no one has combined these two compounds 
to obtain the highly successful transformation obtained 
by this invention. 
The methodology of this invention has been gener 
ally designated 2PC or dual polycation. The 2PC trans 
fection protocol involves the coordination or combina 
tion of two chemicals, a polycationic compound and 
cationic liposomes. Using the methodology of this in 
vention, the host cells or protoplasts derived therefrom 
are treated with a polycationic compound and the for 
eign DNA to be introduced into the host is exposed to 
cationic liposomes. The DNA cationic liposome com 
plex resulting therefrom is then contacted with the host 
cell polycationic complex. Evidently, this invention is a 
strikingly simple and elegant protocol. In view of this, 
the 2PC method is believed to be a highly desirable 
alternative to other known transfection protocols such 
as electroporation or polyethylene glycol. The 2PC 
method also provides a higher degree of transformed 
cell viability than other known methods. 
The underlying theoretical mechanism of the 2PC 
protocol is not well understood although the results of 
practicing the protocol are well established as set forth 
herein. This invention exploits the discovery that a 
synergistic interaction advantageously effecting host 
cell transformation occurs between the polycation com 
pound and the cationic liposomes. A possible hypothe 
sis explaining this invention is extant and is set forth 
below. However, it will be appreciated that regardless 
of the ultimate accuracy of this hypothesis, the method 
ology disclosed herein for effecting efficient cellular 
transformation is not affected by the accuracy of this 
hypothesis. 
It is currently believed that foreign or nonnative 
DNA is introduced into a host cell using the teachings 
of this invention when a synergistic reaction occurs by 
virtue of charge interaction arising from the described 
treatment of the transfecting DNA and pretreatment of 
the host cell with polycation. This interaction of 
charges leading to DNA transfer occurs because of the 
attraction of charges on aggregates, (formed by previ 
ous exposure of DNA to a suspension of cationic lipo 
somes) to the charges present on host cells following 
host cell pretreatment with a polycation compound. In 
particular, it is the current hypothesis that following 
treatment of the correct ratio of foreign DNA to a 
cationic liposome suspension,‘the DNA adheres to the 
outside of the aggregate formed from the interaction of 
the treated DNA and the liposomes. 
The putatively, negatively charged foreign DNA 
complexes or aggregates are believed to be attracted to 
the plasmalemma of the host cell following host cell 
treatment with a polycation compound which changes 
5,286,634 
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at least part of the overall charge of the host cell from 
negative to positive resulting in attractive forces be 
tween the putatively, negatively charged DNA aggre 
gates and the putatively, positively charged host cell. It 
will, of course, be understood that the foregoing is 
merely a hypothesis and that the success of the 2PC 
method is no doubt dependent on numerous complex 
physiological processes. A fuller discussion of the the 
ory explaining the 2PC methodology is set forth below 
under the appropriately entitled subheading. 
Prior to discussing particular preferred embodiments 
of this invention, a general discussion of the methodolo 
gies involved in the invention and the host cells upon 
which this methodology can be practiced is set forth. 
These discussions are grouped by subheading to facili 
tate understanding of this invention. 
Host Cells 
This invention is applicable to all cellular life forms. 
The application of the methodology disclosed herein is 
believed to be most applicable to animal cells generally 
and mammalian cells in particular, and plant cells espe 
cially plant cells of the subtype protoplasts. The reason 
for this belief is discussed in part in the Background Of 
The Invention section in which the problems associated 
with known transfection protocols is set forth. 
Any cell can be used with this invention. As set forth 
in FIG. 8, this invention is exempli?ed herein through 
use of monocotyledonous and dicotyledonous cells. In 
particular, the maize and tobacco plants which exem 
plify monocot and dicot plants respectively were used. 
In all instances, stable transformation of host cells was 
achieved. Also, animal cells such as mammalian cells as 
exempli?ed by Chinese hamster ovary (CI-IO), mouse 
embryo 3T3, or human diploid ?broblast cells can be 
used. It will be understood by one skilled in the art that 
certain modi?cations of this protocol, all within the skill 
of the ordinary practitioner, will have to be made de 
pending on the particular cell being transformed. By 
way of example, the media used during the transforma 
tion process will have to change for each type of cell so 
that the media is compatible with the particular cell line 
to be transformed. Among the reasons such media com 
patibility is required is to maintain the proper osmolality 
for cells in a particular medium. Examples of the differ 
ent types of media that can be used include MS or N6 
media for corn; NTl media for tobacco; and for CH0 
cells, a medium comprising alpha medium and 10% 
fetal calf serum (10). 
The Polycation Compound 
The use of polycationic compounds to help effect 
transformation of cells is known (8,30). In particular, 
use of the polycation compound, hexadimethrine bro 
mide sold under the brand POLYBRENE or other salts 
of hexadimethrine is known. Also, use of polycationic 
compounds such as the salts of poly-L-ornithine or 
other salts of polyamines have been known to facilitate 
inoculation of protoplasts with viruses (28). Other ex 
amples of polycations or salts of polyamines that could 
be used in the ZPC method of this invention are salts of 
poly-L-arginine, poly-L-lysine, poly-D-lysine, polyal 
lylamine and polyethleneimine. In addition, any polyca 
tionic compound prepared from the combination of any 
compound containing at least two good leaving groups, 
such as dihalogenated compounds especially dibromide 
and diiodide but less desirably di?uoride, or ditosylates 
and any poly(tetraalkyl-substituted amine) containing 
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chains of two or more carbons between the amine 
groups could also serve as an effective polycationic 
compound for this invention. In the instance of the salt 
of hexadimethrine, the compound containing two good 
leaving groups could be 1,3 dibromopropane and the 
poly(tetraalkyl substituted amine) is N,N,N’,N'-tet 
ramethylhexamethylene diamine. In this case, the poly 
amine is a diamine. Indeed, almost any combination of 
alkyl or xylyl groups attached to a basic carbon chain 
and combined using the aforementioned good leaving 
groups would be effective polycations. However, for 
reasons regarding weakening the basicity of the com 
pound, it is believed that aryl groups attached directly 
to nitrogen compounds would be less effective than the 
foregoing compounds. 
Other compounds that behave in a fashion similar to 
polycationic compounds can also be used. For example, 
polyglycols such as polyethylene glycol or polypropyl 
ene glycol solutions in a mixture with a mannitol solu 
tion containing calcium ions would be effective as a 
substitute for a polycationic compound. Other inert 
sugars other than mannitol could be used to adjust os 
moticum. Indeed, any polyglycol would likely work in 
this context and any divalent cation such as magnesium 
could be substituted for the divalent cation calcium. 
Cationic Liposomes 
The cationic liposomes of this invention are prepared 
by methods well known in the art (10) and are available 
commercially, for instance under the name LIPOFEC 
TIN. Cationic liposome compounds comprise a suspen 
sion of cationic liposomes, which are vesicles compris 
ing an arti?cial lipid bilayer. The cationic liposomes can 
be constructed by any known means such as the means 
set forth in the aforementioned reference or, as noted, 
by purchasing such cationic liposomes commercially. 
Theoretical Hypothesis 
The protocol for transfection with 2PC is straightfor 
ward, uses easily available chemicals and requires no 
expensive equipment. Using both maize and tobacco it 
has been shown that the 2PC method promotes trans 
formation in both monocots and dicots. 
The precise mechanism of interaction of polycationic 
compound and cationic liposomes in promoting the 
2PC synergistic response is not understood. However, it 
is known from use of cationic liposomes alone for DNA 
transformation that cationic aggregates were produced 
when DNA was mixed with the cationic liposomes in a 
ratio of 1:5. It was thus proposed that these positively 
charged aggregates would fuse with negatively charged 
cell membranes (10). It is believed that if the concentra 
tion of DNA relative to cationic liposomes was in 
creased, negatively charged aggregates carrying a large 
amount of DNA would probably be produced because 
the increased number of DNA molecules used should 
adhere as efficiently to the outside as to the inside of a 
group of the cationic liposomes. Then, the putative 
negatively charged DNA complexes should subse 
quently be attracted to plasmalemma which has been 
treated with polycation to change at least some of the 
overall charge from negative to positive. Success of the 
2PC method is probably dependent on several complex 
physiological processes, but data is extant to support the 
aforementioned theory. 
Transfection of maize protoplasts by cationic lipo 
somes alone was most successful when 0.] or 0.5 ug 
DNA was complexed with 25 ug cationic liposome 
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(DNA/lipid ratios of 1:250 or 1:50) and most erratic 
when DNA/lipid ratios were 1:2.5, 1:1.25 or 2:1 when 
10, 20 or 50 ug DNA was used. These observations are 
consistent with the hypothesis that the former aggre 
gates should have been largely positive, and that the 
latter (according to the instant hypothesis) could have 
been largely negative and less efficiently attracted to 
the plasmalemma. The ZPC method was most successful 
when cationic liposomes were complexed with 10 or 20 
ug DNA (DNA/lipid ratios of 1:2.5 or 1:1.25) suggest 
ing that the observed efficiency of transfection was due 
to the expected interactions of negatively charged cati 
onic liposome DNA complexes with a positively 
charged polycation coated protoplast membrane. When 
applying the 2PC method of this invention to other 
cells, for example embryogenic maize, or to large DNA 
molecules, it is desirable to adjust the DNA/lipid ratio 
in a predetermined manner to facilitate such applica 
tions as exempli?ed by maximizing the amount of DNA 
as compared to the amount of lipid in the DNA/lipid 
ratio. 
When one concentration of DNA (2ug) is complexed 
with cationic liposomes in ratios of 1:1, 1:2.5 and 1:5 and 
then electrophoresed for 3 h in a 0.3% gel, different 
patterns of migration are seen (FIG. 9 lanes 2, 3 and 4). 
The DNA control migrates as expected toward the 
positive electrode, the 1:1 and 1:2.5 mixed aggregates 
migrate like the control (although some material stays at 
the origin), and the 1:5 mixture stays entirely in the 
originating well. This indicates that the former com 
plexes may be negative as predicted, while the latter are 
positive as proposed (10). 
When 30 ug polycation compound is added to these 
various DNA/ cationic liposome mixtures, no migration 
is seen at all and the complexes are precipitated at origin 
(FIG. 9 lanes 5, 6 and 7). This ?nding suggests that a 
second mechanism might be involved in the interaction 
of the 2PC method, i.e., the precipitation of negatively 
charged DNA complexes onto the polycation coated 
surface of the plasma membrane. 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
Cells 
A maize Black Mexican Sweet suspension culture, 
BMS-M, was used to exemplify application of the 2PC 
method. BMS-M cells were maintained in medium con 
taining MS salts (11) supplemented with (1'1) 2 mg 
2,4-D, 0.5 mg thiamine, 20 g sucrose, 150 mg aspara 
gine, and 250 mg glucose (MS2D)(12). Suspension cul 
tures were routinely subcultured at 7 d intervals (0.004 
g per ml initial inoculum) and grown with shaking at 
150 rpm in the dark at 28° C. Under these conditions, 
cell populations were always in exponential growth 
between 2 and 6 d after inoculation. Population dou 
bling time (Td), determined by increments in fresh 
weight, was usually 24 to 36 h. 
Maize embryogenic callus lines were derived from 
immature F1 embryos from crosses of inbred A188 X 
Mutator (Muz) lines. Cultures of 9- to 12'day embryos 
(approximately I to 2 mm in length) were initiated by 
standard methods(l3) on N6(l4) basal medium supple 
mented with 20 g sucrose, 0.74 mg/liter 2,4-D, 6 mM 
asparagine, 5.5 mM myoinositol, 12 mM proline, and 
0.3% Gelrite. One month after culture initiation, the 
proline concentration was reduced to 6 mM. Cultures 
were incubated at 28° C. in the dark. After two weeks 
all embryos were moved without selection to fresh 
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medium. Type II embryogenic callus was thereafter 
selected and propagated biweekly. 
Protoplast Isolation 
For application of the 2PC method to plant cell trans 
fection protocols, transfection using protoplasts is rec 
ommended to facilitate DNA movement into the host. 
Ideally, the protoplasts selected should be capable of 
regenerating plants. 
BMS-M cultures in log phase growth were harvested 
4 d after transfer. Growth medium was decanted and 
the cells were plasmolyzed for 30 min at 25 rpm in 
MSZD with 8% mannitol (MS2D8M). Protoplasts were 
then isolated by known methods (12). Approximately 
0.5 g fresh weight callus was incubated with mixing at 
25 rpm at 28° C. for 4 h in 20 ml 2% cellulase and 0.25% 
pectinase dissolved in 80 mM calcium chloride, 0.2 M 
mannitol, pH 5.0. After incubation in enzyme mixture, 
the protoplast preparation was gently ?ltered ?rst 
through a 70-um nylon mesh screen and subsequently 
through three 46-um nylon mesh screens. Enzymes 
were removed from the protoplasts by two 20 ml 
washes with MS2D6M. Cells were collected by centrif 
ugation (50><g for 5 min) and resuspended in 5 ml 
MS2D6M for gene transfer. Protoplast viability after 
?ltration and washing was tested by staining with ?uo 
rescein diacetate (15) and ranged from 75% to 95%. 
Contamination of the protoplast preparation with 
whole cells was determined using extant methodology 
(16). No intact cells remain after this treatment. 
Protoplasts from A188/Mu2 (a cell line known to 
regenerate plants) were prepared from callus tissue by 
existing methodology (l7) and washed in N6 with 8% 
mannitol (N68M). 
Plasmid DNA 
Three transforming plasmids were used: pCaM 
VI1CN (18) containing the cauli?ower mosaic virus 
(CaMV) 35S promoter, an Adhl derived intron (I1), the 
chloramphenicol acetyl transferase (CAT) coding se 
quence, and nos 3'; pCaMVNeo (7) containing the 35S 
promoter, the neomycin phosphotransferase gene (npt 
II) from Tn5, and nos 3'; and pZASO (19), containing 
the 35S promoter, the B-glucuronidase (GUS) coding 
sequence and nos 3’. Plasmid DNA was prepared by 
standard methods (20). Any other marker cassette or 
cassette capable of expression in the target host cell can 
be used for transformation. 
Probes to detect integration of transfected genes into 
host DNA include a 1.0 kb BamHI fragment containing 
nptIl structural regions from pCaMVneo and a PM 
EcoRI fragment from pZA50 containing 355 GUS nos 
3’ sequences. The isolated fragments were labeled with 
32F and a nick translation kit. 
Transfection of Cells by Polycation Pretreatment Alone 
After the ?nal wash, protoplasts were resuspended in 
MS2D6M. Stock solutions of the polycationic com 
pound hexadimethrine bromide sold under the brand 
POLYBRENE were freshly prepared for each experi 
ment. The concentration of hexadimethrine bromide in 
these stock solutions was 10 mg/ml in phosphate buff 
ered saline, pH 7.0, but any concentration compatible 
with the solubility properties of hexadimethrine bro 
mide (or other polycation) would have been satisfac 
tory. The ?nal volume of each transfection mixture was 
1.0 ml and contained 2X10‘5 protoplasts in 0.5 ml 
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MS2D6M, 30 ug of the polycationic compound in 0.1 
ml MS2D6M, and the desired concentration of DNA in 
0.4 ml MS2D6M. The diluted polycationic compound 
solution was added to the protoplast suspension, mixed 
gently, and then transferred to a holding means such as 
a petri dish. The DNA suspension was then added 
slowly, most preferably by a dropwise methodology, 
into the polycation protoplast suspension. This cell 
polycation-DNA mixture was placed on a gyro rotary 
shaker platform at 25 rpm for 15 min and then incubated 
without shaking at 28° C. for 6 h. After the 6 h incuba 
tion, the mixture was diluted by adding 4.0 m1 
MS2D6M and incubated further at 28° C. either for 
assay of transient gene expression or selection of stable 
transformants. 
Transfection of Cells by Cationic Liposome 
Pretreatment of DNA Alone 
Cationic liposomes in suspension were obtained com 
mercially under the brand LIPOFECTIN (1 mg liposo 
mes/1 ml). Protoplasts (2X106 in 0.9 ml MS2D6M) 
were moved to a 60 mm petri dish. Transfecting DNA 
was prepared by adding 50 ul of a 1:1 dilution of cati 
onic liposome stock suspension in water to 50 111 (de 
sired concentration) DNA in water. This cationic lipo 
some-DNA mixture (?nal concentration 25 ug cationic 
liposome plus DNA in 0.1 ml) was then incubated for 15 
min at room temperature to allow the formation of 
lipid/DNA complexes. The cationic liposome DNA 
aggregate mixture was added dropwise to the proto 
plasts. The ?nal protoplast-cationic‘ liposome-DNA 
mixture was then rotated at 25 rpm for 15 min and 
incubated for 6 h at 28° C. before dilution with 4.0 ml 
MS2D6M. 
Transfection of BMS-M Cells by 2PC 
This method combines pretreatment of the recipient 
cells by polycation compound and pretreatment of the 
transfecting DNA with cationic liposomes. Protoplasts 
(2 X 106 in 0.5 ml MS2D6M) were pretreated as set forth 
with 30 ug of the polycation compound in 0.1 ml me 
dium for not more than approximately twelve hours or 
for not less than approximately one minute but most 
preferably for approximately ?fteen minutes. Treatment 
of animal cells including mammalian cells can be for as 
long as twenty-four hours. DNA-cationic liposome 
aggregates or complexes were produced as set forth by 
addition of 50 ul of the desired concentration of DNA in 
water to 50 ul of a cationic liposomes suspension (previ 
ously prepared by making a 1:1 dilution of a cationic 
liposomes stock suspension with water) and subsequent 
incubation for 15 min at room temperature. An addi 
tional 0.3 ml water was then combined with the DNA 
cationic liposome complex and it was then added, pref 
erably slowly, and most preferably dropwise, to the 
polycation treated protoplasts which had previously 
been placed in a holding means. The protoplast polyca 
tioncationic liposome-DNA mixture was rotated for 15 
min at 25 rpm, incubated for 6-12 h at 28° C., and di 
luted with 4.0 ml MS2D6M. 
Transfection of Al88/Mu2 Protoplasts by 2PC 
Methods were identical to those described for 
BMS-M except that the growth medium with mannitol 
used at every step was N68M rather than MS2D6M. 
The resultant transfection mixture containing either 
the Al88/Mu2 or the BMS-M protoplasts are jointly 
and individually referred to as a diluted transfection 
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mixture for sake of‘ simplicity in further elaboration of 
the protocol of this invention as set forth hereinafter. 
Selection For Stable Transformants 
After transfection treatment of BMS-M protoplasts 
the diluted transfection mixture was incubated without 
shaking at 28° C. in sealed holding vessels such as petri 
dishes for 14 (1. Small clusters of dividing cells, the 
dividing microclusters, were then recovered by gentle 
resuspension, for instance using a rubber policeman, and 
centrifuged preferably at 50X g for 5 min. Part, approxi 
mately 1 ml, of the supernatant was removed, leaving a 
remaining volume of 4.0 ml. Four petri dishes were then 
prepared, each with 1 ml of this suspension plated on 
nonselective MS2D solid medium containing 0.3% Gel 
rite and 25% conditioned medium (CM) (12). CM was 
previously prepared for addition to Gelrite medium by 
?ltration of the supernatant of BMS-M cells in logarith 
mic growth through S-u, 0.45-u and 0.22-u membrane 
?lters just before use. After 7 d, well-developed 2~mm 
microcalli were randomly picked and transferred to 
selective MS2D, 0.3% Gelrite plates containing 200 
ug/ml kanamycin. These were incubated further at 28° 
C. for 7-14 d. Faster growing microcalli were then 
picked for further subculture and preparation of geno 
mic DNA for use in Southern blot analysis. 
Chloramphenicol Acetyl Transferase (CAT) Assays 
Transfected protoplasts were incubated for 
40 h before assay for CAT activity (21). Silica gel thin 
layer chromatography (TLC) plates were exposed to 
X-ray ?lm for 18 h at room temperature. Protein con 
centration was determined by the Bradford method 
(22). 
Neomycin Phosphotransferase Assay 
Neomycin phosphotransferase activity in selected 
kanomycin-resistant stable transformants was tested by 
the method of Cabanes-Bastos et a1. (23). 
Genomic DNA Isolation and Southern Blot Analysis 
Genomic DNA was isolated from microcalli by a 
miniprep method (24). Restriction enzymes in particular 
Barnl-II, EcoRV, EcoRI and PstI were used for geno 
mic DNA digestion as is well known in the art for such 
enzymes. Approximately 5 ug of high molecular weight 
DNA was digested with 3 to 5 units of restriction en 
zymes per ug DNA and subjected to electrophoresis 
through 0.8% agarose gels. UV-nicked DNA fragments 
were transferred to a nylon transfer membrane such as 
a Genetran membrane by the procedure of Southern 
(25) for 48 h. After baking for 2 h at 80° C. under vac 
uum, hybridizations were carried out in 50% form 
amide, SXDenhardt’s, SXSSC, 100 ug/ml denatured 
salmon sperm DNA, 1% SDS, 5% dextran sulfate, and 
2X 107 cpm 32P-labelled DNA at 42° C. for 36 h. Filters 
were washed in 50% formamide, SXSSC, 0.2% SDS 
for 30 min at 42° C., then washed two times for 20 min 
each in 2 X SSC, 0.1% SDS, and two times in 0.1 X SSC, 
0.1% SDS. The ?rst three washes were performed with 
agitation at room temperature and the last at 65° C. 
Filters were ?nally exposed at —70° C. for l-2 d to 
Kodak XAR-S ?lm with an intensifying screen such as 
the lightening plus brand. Filters were prepared for 
rehybridization by removal of probe with 3 to 4 wash 
ings at 95° C. in 0.1XSSC, 0.1% SDS. 
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Transient Gene Expression in BMS-M Protoplasts 
After 2PC Transfection 
Transient activity of the CAT reporter gene indicates 
successful plasmid DNA transfer and gene expression. 
CAT gene activity (% of 14C chloramphenicol con 
verted to acetylated forms) was determined after incu 
bating BMS-M protoplasts for 40 h after transfection 
with the 2PC method. This CAT gene activity was 
compared to other prior art cationic transfection treat 
ments, namely, use of cationic liposomes alone, speci? 
cally, use of the cationic liposome brand LIPOFECTIN 
and a polycation compound treatment alone, speci? 
cally, use of the polycation compound brand POLY 
BRENE. In each experiment, the CAT gene activity 
was compared with that in control samples with cation 
treated cells but with no added DNA. For all 3 cationic 
methods good transient CAT expression was obtained 
over a wide range of DNA concentrations (FIGS. 1 and 
2 and Tables 1 and 2.) FIG. 1 and Table 1 show that 
after polycation compound treatment CAT activity 
increases from 1 to 6% with increasing concentrations 
of transfecting DNA up to 20 ug. On the other hand, 
cationic liposome treated cells express CAT activity at 
all DNA concentrations from 0.1 ug to 50 ug. Transient 
CAT gene expression seen after plasmid transfer with 
2PC is also dependent upon DNA concentration and 
varies from 2 to 49% per 100 mg protein (FIG. 1, Table 
l) or from 8 to 65% when total sample proteins (Table 
2) are assayed. Clearly, CAT activity obtained from 
cells treated with the 2PC method is markedly superior 
to the other cationic treatments used alone. An autora 
diogram of a TLC plate showing CAT activity in one 
experiment after polycation compound, cationic lipo 
some or 2PC treatment is shown in FIG. 2. 
Synergistic Effect with 2PC Transformation 
Using 2PC resulted in an increase in transient gene 
expression (Tables 1 and 2) when compared to method 
ology known in the prior art. Published theories (8, 10) 
of polycation compounds alone and cationic liposome 
action alone in the transformation of host cells failed to 
indicate that any synergistic effect would be extant 
between these two chemicals. 
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The data in Table 2 which is derived from values of 45 
CAT expression in total crude lysates of 2><106 proto 
plasts in each treatment sample shows that observed 
CAT activities after cellular transformation with 2PC 
range from 37 to 65% using 5-50 ug DNA which is 
treated with cationic liposome and transfected into cells 
treated with a polycationic compound. The expected 
additive values obtained after polycationic compound 
plus cationic liposome treatment would have been 10 to 
13% and the'increased synergistic effect of the 2PC 
methodology of this invention was a startling 3.6 to 
5.1-fold increase over the expected values. Later, when 
total protein concentrations of treated protoplast sam 
ples were measured at the time of CAT assay, it was 
found that the amount of protein varied between sam 
ples and usually ranged from 150 to 250 mg. This sam 
pling error probably evidences the difficulty of making 
accurate dilutions of protoplasts suspended in medium 
and loss of tissue in preparation of the crude cell lysate. 
Therefore, in subsequent experiments (Table 1) all CAT 
activity was expressed as a function of protein quantity. 
Again, a synergistic effect of combined or coordinated 
treatment with polycation and cationic liposome is seen 
in Table 1 when transfecting DNA concentrations are 
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5-20 ug. In this instance, the multiplicative increase is 2 
to 5-fold over the expected additive effects of the poly 
cation and cationic liposome treatments. 
The amount of transfecting DNA used affects the 
reliability of expression using the 2PC invention as well 
as degree of synergism arising from the 2PC methodol 
ogy. Synergistically elevated transient expression of the 
CAT genes was seen in 11/11 trials when 10-20 ug 
DNA was transfected. However, when other concen 
trations of transfecting DNA were used (0.1, 0.5 or 50 
ug) only 6/ 13 trials showed the 2PC effect. 
The 2PC method is clearly more effective in promot 
ing transformation measured by transient gene activity 
than polycation compound or the cationic liposome 
methods used alone. Stable transformants occurred in 
up to 40% of unselected colonies after 2PC treatment; 
transformants occurred in only 3-8% of colonies after 
polycation or cationic liposome treatment alone. This 
finding is also manifest by results obtained in experi 
ments testing CAT gene transfer to protoplasts derived 
directly from A188/Mu2 F1 embryogenic maize callus. 
In these tests (Table 3 and FIG. 3) neither polycation 
nor cationic liposome methods (using 2><106 proto 
plasts and 20 ug DNA) promote signi?cant, detectable 
gene transfer. 2PC, however, gave positive results and 
the measured CAT activity at 40 h was 1.4 to 10.8%. 
Expectedly, protoplasts derived from cultures in loga 
rithmic growth are more transformation competent by 
polycation compounds and cationic liposome methods 
than protoplasts derived from cultures in lag phase. 
Apparently, the observed increased efficiency of the 
2PC methodology has succeeded in overcoming this 
defect, so that even slowly dividing or nondividing cells 
can be transformed. The callus mass of Al88/Mu2F1 
embryogenic cultures enlarges 3-4 fold in 2 weeks, but 
BMS cells in culture have a 24-36 h doubling time. 
The efficiency of the 2PC method was compared 
with direct gene transfer by electroporation, a nonca 
tionic method that uses protoplasts. In this comparison, 
electroporation (3X106 protoplasts, 150 V and 800 uF 
of 10 ug quantities of DNA) usually yields 10-20% 
conversion of 1"C chloramphenicol. 2PC mediated 
transfection with 10 ug DNA produces an average 
value of 71% conversion for 2 X 106 treated protoplasts. 
Protoplast Viability After Cationic Treatments Is 
Extraordinarily High 
Percentage of viable cells at 0, 6, 12 and 24 h after 
transfection was estimated by the ?uorescein diacetate 
method (15) (FIG. 4). Data represented in this histo 
gram show that neither polycation compound, cationic 
liposome nor 2PC treatments cause cytotoxicity. The 
number of viable cells is in all instances 100% of control 
values for untreated protoplasts at the four time points 
checked. The unprecedented lack of cell damage 
caused by transfection with these techniques may occur 
because cationic methods for gene transfer probably 
exploit the natural processes of plasmalemma fusion and 
endocytosis (10,8). Lack of cytotoxicity might also play 
a role in the above mentioned superior effectiveness of 
2PC methods compared with electroporation. By com 
parison use of electroporation can and oftentimes does 
cause a 30 to 50% drop in viability of transfected proto 
plasts by 24 h (8) and often causes a lower yield of 
recovered protein in sample lysates, which implies cell 
loss. 
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Stable BMS-M Transformants Were Obtained By 2PC 
Transfection 
Stable integration of transfecting DNA may occur 
after introduction to host cells using 2PC methodology. 
This requires that the entire transforming cassette (the 
structural gene and the attached regulatory compo 
nents) reach the host nuclei in an undegraded form and 
that the cassette will remain undegraded until they are 
integrated into the new host genome. Further, expres 
sion of integrated transforming genes is necessary for 
the phenotypic recognition of stable genetically altered 
transformants. This second event is dependent upon 
successful molecular recombination of the entire trans 
forming gene, including both structural and regulatory 
components, into a region of host DNA which will 
allow these sequences to remain unmethylated. It is 
evident that this invention allows-for recovery of stable 
transformants after transfection by 2PC methodology 
of at least two different genes: nptII in pCaMVNeo and 
B-glucuronidase (GUS) in pZA50. Anyone skilled in 
the art will appreciate that this invention is not limited 
to the aforementioned two genes because this gene 
transfer methodology, as is true with all gene transfer 
methodologies is not limited by a particular DNA se 
quence. The stable transformants were recovered by 
the method shown in FIG. 5. 
Transformed protoplasts were maintained for 4 
weeks on nonselective medium before randomly picked 
Z-mm microcalli were moved to selective medium for 
tests of nptII expression (neomycin resistance) or to 
microtiter dishes for histochemical tests of GUS enzy 
matic activity (26). When randomly selected microcalli 
were transferred after seven days to ZOOug/ml Kanamy 
cin medium, 23% of these microcalli showed moderate 
to rapid growth on the antibiotic. Kanamycin resistant 
(Kan ®) nptII-containing microcalli were recovered 
from 23% of all microcalli showing moderate to rapid 
growth on 200 ug/ml kanamycin after 7 d. GUS activ 
ity was observed in 9% of randomly picked microcalli. 
Stringent proof of stable transformation resulting 
from integration of a foreign gene into host DNA re 
quires molecular evidence for integration of the trans 
fecting gene and biochemical demonstration of occur 
rence of the expected gene product. Both of these crite 
ria for the two donor genes used have been satis?ed. 
After restriction with BamHI and hybridization with a 
1.0 kb BamHl nptII probe, genomic DNA isolated from 
Kan® microcalli after 2PC transfection revealed the 
characteristic 1.0 kb nptII-containing fragment. Restric 
tion of two of these Kan ® genomic DNAs with 
EcoRV, an enzyme which cuts at one site within the 
transfecting plasmid and at several external sites within 
the maize genome, reveals several patterns of bands 
hybridizing to the BamHI probe (FIG. 6, lanes 0 and d). 
This indicates nptII integration at different independent 
genomic sites, at least 4 in each of the two examples 
shown. Neomycin phosphotransferase activity in sev 
eral Kan® transformants was assayed by the TLC 
method of Cabanes-Bastos et al.(23) (FIG. 7). Lanes 2, 
3, 4 and 10 show evidence of phosphorylated kanamy 
cin in extracts of 3, ZPC-transformed Kan ® colonies. 
After transformation with pZA50, genomic DNA of 
one GUS-positive transformant was tested for GUS 
gene integration (FIG. 8, lane BMS). In this instance 
PstI and EcoRI, restriction enzymes which digest at the 
5' and 3’ ends of the GUS cassette, were used to digest 
genomic DNA which was then probed with the homol 
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ogous 2.85 kb PstI-EcoRI region obtained from pZA50. 
A positive hybridization signal was obtained in a 2.85 kb 
genomic DNA band. As noted above, the GUS gene 
was expressed in 10/ 1 l4 microcalli tested. 
Gene transfer by the 2PC method was also tested in 
protoplasts derived from tobacco line NTl (27). After 
transfer of pZASO, 100 colonies were grown on nonse 
lective medium as described for maize protoplasts in 
FIG. 5. GUS activity was demonstrated in 24/100 sta 
ble transformants and one of these was tested for the 
integration of the GUS cassette (gene and regulatory 
regions) (FIG. 8, lane NTl). The genomic DNA of this 
transformant included the characteristic 2.85 kb GUS 
containing band. This is evidence of the widespread 
applicability of the ZPC method to all cells including 
tobacco and corn protoplasts. 
It will be understood that the embodiments described 
herein are merely exemplary and that a person skilled in 
the art may make any variations and modifications with 
out departing from the spirit and scope of the claimed 
invention. All such modifications and variations are 
intended to be included in the scope of the invention, as 
defined in the appended claims. 
TABLE 1 
Chloramphenicol acetyl transferase activity per 100 mg 
protein in BMS-M protoplasts after transformation with 
pCaMNLCN by cationic methods. 
DNA concentration (ug) 
Treatment 0 0.1 0.5 5 10 20 50 
PH 0.1” 0.2 1.0 3.4 4.6 6.2 1.4 
LF 0.1 4.9 10.7 2.1 1.6 3.6 3.0 
ZPC: Observed 0.2 4.6 4.6 12.1 38.5 49.4 1.9 
values 
Expected additive — 5.1 11.7 5.5 7.2 9.8 4.4 
effect 
Fold increase — — — 2.2 5.3 5.1 — 
No. of trials -- — i 2/2 2/2 3/3 I 
showing positive 
synergistic 
response 
“CAT activity is expressed as the % of 1‘C chlorampheicol convened to acetylated 
products (1- and 3- monoacetyl chloramphenieol). 
‘Average values from 2-3 independent experiments. 
TABLE 2 
Chloramphenicol acetyl transferase activity in total lysate 
from 2 X IOGBMS-M protoplast samples after cationic 
transfection of pCaMVLCN. 
DNA concentration (gg) 
Treatment 0.5 5 10 20 50 
PB 1.0a", 4.8 9.8 8.22 1.58 
LF 12.2 2.7 2.9 5.75 8.6 
2PC: Observed 8.3 29.0 64.6 54.3 36.9 
values 
Expected 13.2 7.5 12.7 14.0 10.2 
additive effect 
Fold increase — 3.8 5.1 3.9 3.6 
No. of trials 5 § 3/3 3/ 3 5 
showing positive 
synergisitic 
response 
nCAT activity is expressed as in Table I. 
I’Average values from 3-4 independent experiments. 
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TABLE 3 
Transient expressions of chlorunphenicol acetyl transferase 
activity"l after direct gene transfer by cationic treatments 
to protoplasts derived from muss/Mal 60.1370 
embgogenic callus. 
Treatment 
PB LF 2PC 
l -- 0.21 
2 .25“ .2 
3 -— .07 
5.01 
10.8 
1.35 
‘CAT activity is expressed u described in Table 1. 
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What is claimed is: 
l. A method for transforming a cell comprising 
treating for a predetermined time a host cell with a 
solution of a polycation compound to form a cell 
polycation complex; 
treating DNA nonnative to said host cell with a sus 
pension of cationic liposomes to form a DNA lipo 
some complex at a predetermined DNA/lipid ra 
tio; 
combining said DNA liposome complex with said 
cell polycation complex thereby transforming said 
host cell with said nonnative DNA. 
2. The method of claim 1 wherein said cell has as its 
outer boundary a membrane. 
3. The method of claim 1 wherein said cell reacts 
with said polycation compound solution for between 
one minute and three hours prior to combining said 
polycation compound solution with said DNA cationic 
liposome complex. 
4. The method of claim 1 wherein said cell is a proto 
plast which reacts with said polycation compound solu 
tion for substantially one quarter of an hour prior to 
combining with said DNA cationic liposome complex. 
5. The method of claim 1 wherein said polycation 
compound is a salt of hexadimethrine. ‘ 
6. The method of claim 1 wherein said polycation 
compound is selected from salts of the group consisting 
of poly-L-ornithine, poly-L-arginine, poly-L-lysine, 
poly-D-lysine and polyethleneimine. 
7. The method of claim 1 wherein said cell is a mono 
cotyledonous plant cell. 
8. The method of claim 1 wherein said cell is from a 
maize cell. 
9. The method of claim 1 wherein said plant cell is a 
dicotyledonous cell. 
10. The method of claim 1 wherein said cationic lipid 
comprises a salt of a synthetic cationic lipid designated 
N-[l-(2,3-dioleyloxy)propyl]N,N,N trimethyl 
ammonium. 
11. The method of claim 1 wherein said cationic lipo 
somes interact in the presence ‘of said DNA to form 
liposome DNA aggregates. 
12. The method of claim 1 wherein said DNA is 
treated with said suspension of cationic liposomes in a 
DNA/lipid ratio between 1:25 and 1:125. 
13. The method of claim 1 wherein said DNA is 
treated with said suspension of cationic liposomes to 
maximize said DNA/lipid ratio. 
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UNITED STATES PATENT AND TRADEMARK OFFICE 
CERTIFICATE OF CORRECTION 
PATENT NO. :5,236,634 Page 1 of 2 
DATED : February 15, 1994 
INVENTOR(S) : Stadler et al 
It is certified that error appears in the above-indenti?ed patent and that said Letters Patent is hereby 
‘ corrected as shown below: 
Column 2, line 11, "Aqrobacterium-mediated" should read 
--Agrobacterium-mediated-—. 
Column 2, lines 25 and 26, "Aorobacterium-mediated" should read 
—-Agrobacterium-mediated—-. 
Column 2, line 29, "Aqrobacterium" should read 
-—-Agrobacterium——. 
Column 4, line 37, "2PC-" should read —-2PC-treated-—. 
Column 5, line 3, "7 d" should read —--7d---. ‘ 
Column 5, line 25, "phosporylated" should read 
—-phosphorylated—--. 
Column 5, line 30, "structure" should read --structural--. 
Column 10, line 51, "BamHI" should read --BamHl--. 
Column 15, line 47, "BamHI" should read -—BamHl--. 
Column 15, line 48, "BamHI" should read --BamHl--. 
Column 15, line 55, "BamHI" should read --BamHl-—. 
Column 16, line 45, "chlorampheicol" should read 
--chloramphenicol——. 
Column 17, line 41, "427413-7417". should read 
--84:74l3-74l7--. 
Column 18, line 46, "polyethleneimine" should‘ read 
-—polyethyleneimine——. 


